Therapeutic Monitoring Systems Inc.
Andrew J.E. Seely is a distinguished scientist and healthcare professional with extensive experience in thoracic surgery and critical care medicine. Currently serving as a scientist at Ottawa Hospital Research Institute since 2014, Andrew is also the Founder and Chief Science Officer at Therapeutic Monitoring Systems, where the focus is on developing innovative clinical decision support systems for enhancing patient care in critical illness. In addition to these roles, Andrew holds positions as an Associate Professor at the University of Ottawa and as a thoracic surgeon and intensivist at Ottawa Hospital. Andrew's educational background includes a medical degree and PhD from McGill University, a BSc in Honours Physics from Carleton University, and specialized training in thoracic surgery and critical care medicine at the University of Ottawa.
This person is not in any teams
Therapeutic Monitoring Systems Inc.
Therapeutic Monitoring Systems is a venture-funded company developing clinical decision support software for use in critical care medicine. Our CIMVA™ software platform will be used by physicians & nurses in the hospital ICU and emergency department to improve how care is delivered, benefiting both patients and hospitals. CIMVA softwareseamlessly integrates with critical care monitors to analyze patient vital signs, offering novel insights into a patient’s health status currently unavailable using standard of care monitoring equipment. Based on patent protected concepts, TMS believes that harnessing the power of ‘big data’ analytics to complement physician & nurse judgement will materially improve outcomes in the complex care situations that arise in hospital ICUs and emergency departments. Now in studies at hospitals across North America, CIMVA software is architected to facilitate point-of-care use by caregivers on browser-enabled central viewing stations or mobile devices.